Bittoo Kanwar
Net worth: 15 211 $ as of 30/11/2023
Network origin in Bittoo Kanwar first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 14 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bittoo Kanwar via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Administrative Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| GT BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| CYCLO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| IMUNON, INC. | Biotechnology | General Counsel | |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity | |
JMP Securities LLC
 JMP Securities LLC Investment Banks/BrokersFinance Citizens JMP Securities LLC (Citizens JMP) is a full-service investment bank and broker/dealer headquartered in San Francisco, California. The firm was founded by Joseph Jolson in 2002 and was formerly JMP Securities LLC. The firm is a subsidiary of JMP Holding LLC, ultimately held by Citizens Financial Group, Inc. (NYSE: CFG). Citizens JMP provides equity research, institutional brokerage, and investment banking services to public and private growth companies and their investors. They are a research-driven, growth-oriented firm that provides services to small- and mid-sized companies and the institutions that invest in them. The firm specializes in four high-growth sectors of the economy: technology, healthcare, financial services, and real estate. | Investment Banks/Brokers | Analyst-Equity | |
Deutsche Bank AG /UK/
 Deutsche Bank AG /UK/ Investment Banks/BrokersFinance Deutsche Bank AG /UK/ (Deutsche Bank UK) is the Great Britain-based division of Deutsche Bank AG in Germany, which focuses on retail banking, proprietary management, and private wealth management for individual investors. Established in 1873, the firm is headquartered in London and offers commercial and corporate banking products and services. They promote and coordinate socially responsible activities on behalf of Deutsche Bank and their employees in Great Britain, supporting charities and community organizations within their key focus areas of education, social initiatives, and art. | Investment Banks/Brokers | Corporate Officer/Principal | |
| GENELUX CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| Stony Brook School | College/University | Doctorate Degree | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Operating Officer Director of Finance/CFO | |
| NGM BIOPHARMACEUTICALS, INC. | Biotechnology | Consultant / Advisor Corporate Officer/Principal | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Ernst & Young provides accounting services. Its services include auditing, accounting, tax and transaction services, assurance and advisory business, online transaction advisory and a wide range of financial services. The company was founded by Arthur Young and Alwin C. Ernst in 1881 and is headquartered in Kansas City, MO. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| St. Mary's College of California | College/University | Masters Business Admin | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Graduate Degree | |
| University of Michigan | College/University | Undergraduate Degree | |
Financial Executives International
 Financial Executives International Miscellaneous Commercial ServicesCommercial Services Financial Executives International enhances member professional development through peer networking, career planning services, conferences, publications and special reports, and research. Its members include Chief Financial Officers, Vice Presidents of Finance, Treasurers, and Controllers. The company was founded in December 1931 and is headquartered in Morristown, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Trinity Biosystems, Inc.
 Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Director/Board Member Founder | |
| California Society of Certified Public Accountants | Corporate Officer/Principal | ||
University of Washington Medical Center
 University of Washington Medical Center Other Consumer ServicesConsumer Services University of Washington Medical Center provides healthcare services. It offers gynecology, bariatric, obstetrics, radiology, rehabilitation, neurology, gastric, otolaryngology, ankle, radiology and imaging services. The company was founded on March 1, 1945 and is headquartered in Seattle, WA | College/University | Corporate Officer/Principal | |
Dompe Biotec SpA
 Dompe Biotec SpA Pharmaceuticals: MajorHealth Technology Dompe Biotec SpA (Dompé Biotec SpA) provides biotechnological drugs. Its products are used for the treatment of haematology, infectious diseases, nephrology, oncology, transfusion units and neuro-oncology. The company was founded in 1988 and is headquartered in Milan, Italy | Pharmaceuticals: Major | Director/Board Member | |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Part of Amgen, Inc., Amgen Europe BV wholesales pharmaceutical products. The private company is based in Breda, Netherlands. | Medical Distributors | Director of Finance/CFO | |
Wells Fargo Securities LLC
 Wells Fargo Securities LLC Investment Banks/BrokersFinance Wells Fargo Securities LLC (WFS) is the broker/dealer subsidiary of EVEREN Capital Corp., ultimately owned by Wells Fargo & Co. (NYSE: WFC). Headquartered in New York, WFS delivers a comprehensive suite of banking, capital markets and advisory solutions, such as a full complement of sales, trading and research capabilities, to corporate, government and institutional clients. | Investment Banks/Brokers | Corporate Officer/Principal | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Chief Operating Officer Director of Finance/CFO | |
| ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| EFFECTOR THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Private Equity Investor Director of Finance/CFO | |
| Columbia Business School | College/University | Masters Business Admin | |
| BIOPLUS ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
DoubleRainbow Biosciences, Inc.
 DoubleRainbow Biosciences, Inc. BiotechnologyHealth Technology DoubleRainbow Biosciences, Inc. engages in the development of transformative technologies. It explores essential natural ingredients that enhance daily experience and health through food, beverages, cosmetics, supplements, and other consumer products. The company was founded by Jing Ke Weng and Tian Xu and is headquartered in Cambridge, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Yale School of Medicine | College/University | Doctorate Degree | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
Septerna, Inc.
 Septerna, Inc. Pharmaceuticals: MajorHealth Technology Septerna, Inc. is a biotechnology company located in an undisclosed location. The American company is focused on developing novel, oral small molecule drugs that target the entire class of G protein-coupled receptors (GPCRs). The company's Native Complex™ platform allows for the rapid application of new technologies for industrial-scale drug discovery to address both validated GPCRs and many GPCRs that have been undruggable and unexploited to date. Septerna is building a pipeline of GPCR-targeted, oral small molecule drug candidates, led by its program targeting the parathyroid hormone 1 receptor (PTH1R) for the treatment of hypoparathyroidism. The company was founded in 2022 by scientific founders who have made groundbreaking GPCR discoveries, including Patrick Sexton, Arthur Christopoulos, Robert Joseph Lefkowitz, and Jeffrey T. Finer. Jeffrey T. Finer has been the CEO since incorporation. | Pharmaceuticals: Major | Chief Operating Officer |
Statistics
International
| United States | 43 |
| Netherlands | 3 |
| United Kingdom | 2 |
| Switzerland | 2 |
| Italy | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 10 |
| Finance | 9 |
| Commercial Services | 4 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 44 |
| Corporate Officer/Principal | 36 |
| Independent Dir/Board Member | 17 |
| Director of Finance/CFO | 13 |
| Undergraduate Degree | 12 |
Most connected contacts
| Insiders | |
|---|---|
| Helen Kim | 33 |
| John Smither | 20 |
| Graham Cooper | 14 |
| Charles Olson | 14 |
| Shawn Cross | 13 |
| Earl Douglas | 9 |
| Elizabeth Bhatt | 9 |
| Carolyn Finkle | 7 |
| Holly Schachner | 7 |
| Douglas A. Rich | 6 |
| Randall J. Mrsny | 6 |
| Charlene Banard | 5 |
| Andrew H. Chang | 2 |
| Andy Whitney | 2 |
- Stock Market
- Insiders
- Bittoo Kanwar
- Company connections